BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 28553954)

  • 1. E-cadherin expression is correlated with focal adhesion kinase inhibitor resistance in Merlin-negative malignant mesothelioma cells.
    Kato T; Sato T; Yokoi K; Sekido Y
    Oncogene; 2017 Sep; 36(39):5522-5531. PubMed ID: 28553954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.
    Shapiro IM; Kolev VN; Vidal CM; Kadariya Y; Ring JE; Wright Q; Weaver DT; Menges C; Padval M; McClatchey AI; Xu Q; Testa JR; Pachter JA
    Sci Transl Med; 2014 May; 6(237):237ra68. PubMed ID: 24848258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyses of merlin/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer.
    Shah NR; Tancioni I; Ward KK; Lawson C; Chen XL; Jean C; Sulzmaier FJ; Uryu S; Miller NL; Connolly DC; Schlaepfer DD
    Gynecol Oncol; 2014 Jul; 134(1):104-11. PubMed ID: 24786638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of E-Cadherin and microRNA on FAK Inhibitor Response in Malignant Pleural Mesothelioma (MPM).
    Yuen ML; Zhuang L; Rath EM; Yu T; Johnson B; Sarun KH; Wang Y; Kao S; Linton A; Clarke CJ; McCaughan BC; Takahashi K; Lee K; Cheng YY
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor requires E-cadherin in esophageal cancer and malignant pleural mesothelioma.
    Xin HW; Yang JH; Nguyen DM
    Anticancer Res; 2013 Jun; 33(6):2401-8. PubMed ID: 23749888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma.
    Kanteti R; Mirzapoiazova T; Riehm JJ; Dhanasingh I; Mambetsariev B; Wang J; Kulkarni P; Kaushik G; Seshacharyulu P; Ponnusamy MP; Kindler HL; Nasser MW; Batra SK; Salgia R
    Cancer Biol Ther; 2018 Apr; 19(4):316-327. PubMed ID: 29303405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma.
    Meerang M; Bérard K; Friess M; Bitanihirwe BK; Soltermann A; Vrugt B; Felley-Bosco E; Bueno R; Richards WG; Seifert B; Stahel R; Weder W; Opitz I
    Mol Oncol; 2016 Oct; 10(8):1255-65. PubMed ID: 27378628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LEFTY2 Controls Migration of Human Endometrial Cancer Cells via Focal Adhesion Kinase Activity (FAK) and miRNA-200a.
    Alowayed N; Salker MS; Zeng N; Singh Y; Lang F
    Cell Physiol Biochem; 2016; 39(3):815-26. PubMed ID: 27497669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study.
    Fennell DA; Baas P; Taylor P; Nowak AK; Gilligan D; Nakano T; Pachter JA; Weaver DT; Scherpereel A; Pavlakis N; van Meerbeeck JP; Cedrés S; Nolan L; Kindler H; Aerts JGJV
    J Clin Oncol; 2019 Apr; 37(10):790-798. PubMed ID: 30785827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.
    Kanteti R; Riehm JJ; Dhanasingh I; Lennon FE; Mirzapoiazova T; Mambetsariev B; Kindler HL; Salgia R
    Sci Rep; 2016 Sep; 6():32992. PubMed ID: 27623107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma.
    Sato T; Sekido Y
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-expression of the tumor suppressor NF2/merlin inhibits invasiveness in mesothelioma cells and negatively regulates FAK.
    Poulikakos PI; Xiao GH; Gallagher R; Jablonski S; Jhanwar SC; Testa JR
    Oncogene; 2006 Sep; 25(44):5960-8. PubMed ID: 16652148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells.
    Hwang KE; Kim YS; Jung JW; Kwon SJ; Park DS; Cha BK; Oh SH; Yoon KH; Jeong ET; Kim HR
    Oncotarget; 2015 Oct; 6(30):29482-96. PubMed ID: 26334320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinidine impairs proliferation of neurofibromatosis type 2-deficient human malignant mesothelioma cells.
    Utermark T; Alekov A; Lerche H; Abramowski V; Giovannini M; Hanemann CO
    Cancer; 2003 Apr; 97(8):1955-62. PubMed ID: 12673723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of the tumor suppressor gene NF2, encoding merlin, constitutively activates integrin-dependent mTORC1 signaling.
    López-Lago MA; Okada T; Murillo MM; Socci N; Giancotti FG
    Mol Cell Biol; 2009 Aug; 29(15):4235-49. PubMed ID: 19451229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of autophagy sensitizes malignant pleural mesothelioma cells to dual PI3K/mTOR inhibitors.
    Echeverry N; Ziltener G; Barbone D; Weder W; Stahel RA; Broaddus VC; Felley-Bosco E
    Cell Death Dis; 2015 May; 6(5):e1757. PubMed ID: 25950487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem Cell Factor-Based Identification and Functional Properties of In Vitro-Selected Subpopulations of Malignant Mesothelioma Cells.
    Blum W; Pecze L; Felley-Bosco E; Wu L; de Perrot M; Schwaller B
    Stem Cell Reports; 2017 Apr; 8(4):1005-1017. PubMed ID: 28285878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR Inhibition.
    Quispel-Janssen JM; Badhai J; Schunselaar L; Price S; Brammeld J; Iorio F; Kolluri K; Garnett M; Berns A; Baas P; McDermott U; Neefjes J; Alifrangis C
    Clin Cancer Res; 2018 Jan; 24(1):84-94. PubMed ID: 29061644
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro.
    You M; Varona-Santos J; Singh S; Robbins DJ; Savaraj N; Nguyen DM
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):508-16. PubMed ID: 24094913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADP sensitizes ZL55 cells to the activity of cisplatin.
    Muscella A; Cossa LG; Vetrugno C; Antonaci G; Marsigliante S
    J Cell Physiol; 2019 Apr; 234(4):4409-4417. PubMed ID: 30144378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.